GSK-GLP113121

Study Sponsor: GSK

Study Title

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Monotherapy Study to Determine the Efficacy and Safety of 2 Dose Levels of Albiglutide in Subjects with Type 2 Diabetes Mellitus

Medicine or Vaccine (generic name)

albiglutide

Sponsor Identification Number

GLP113121

Trial Registry Identification Number(#'s)

NCT01733758

Medical Condition

Diabetes Mellitus, Type 2

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=113121

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01733758

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format

Date Added to this Site

July 2016